Sarepta Therapeutics shares owned by Benchmark Investment Advisors
Quarter-by-quarter ownership of Sarepta Therapeutics (SRPT) shares owned by Benchmark Investment Advisors
from 13F filings
Historical chart of Benchmark Investment Advisors investment in Sarepta Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Sarepta Therapeutics held by Benchmark Investment Advisors consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Sarepta Therapeutics by Benchmark Investment Advisors
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-09-30 | $284k | 2.3k | 124.89 |
| 2024-06-30 | $360k | 2.3k | 158.00 |
| 2024-03-31 | $308k | 2.4k | 129.46 |
| 2023-12-31 | $257k | 2.7k | 96.43 |
| 2023-09-30 | $401k | 3.3k | 121.22 |
| 2023-06-30 | $416k | 3.6k | 114.52 |
| 2023-03-31 | $502k | 3.6k | 137.83 |
| 2022-12-31 | $488k | 3.8k | 129.58 |
| 2022-09-30 | $429k | 3.9k | 110.48 |
| 2022-06-30 | $283k | 3.8k | 75.01 |
| 2022-03-31 | $306k | 3.9k | 78.00 |
| 2021-12-31 | $360k | 4.0k | 90.16 |
More positions owned by Benchmark Investment Advisors
View all positions for Benchmark Investment Advisors